MPRINT Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) invites applications from organizations to establish Translational Research Resource Platforms (TRRPs) that will facilitate, support, and conduct therapeutic-focused research for maternal and pediatric populations. As part of the Maternal and Pediatric Precision in Therapeutics (MPRINT) program, awards made under this FOA will focus on resource platforms to support concerted multidisciplinary team science efforts that leverage existing and prospective resources (biobanks, biological sample repositories, omics data, tissue specific genomic/epigenomic atlases, EHRs, etc.) to develop innovative technologies and analytic tools that can advance therapeutic research for maternal and pediatric precision therapeutics.


  • Letter of Intent Due Date(s): November 1, 2022

  • Application Due Date:¬†December 01, 2022

RFA-HD-23-018 Expiration Date December 02, 2022

Agency Website

Amount Description

Application budgets are limited to $670,000 in direct costs and need to reflect the actual needs of the proposed project.

The maximum project period is 5 years.

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

December 1, 2022